Adstiladrin Global Market Report 2025

Adstiladrin Global Market Report 2025 – By Indication (High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC), Other Bladder Cancer Variants), By Distribution Channel (Hospitals And Clinics, Retail And Specialty Pharmacies), By End User (Adult, Geriatric) – Market Size, Trends, And Global Forecast 2025-2034

Name: Adstiladrin Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Adstiladrin Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

Adstiladrin Market Definition

Adstiladrin is a gene therapy medication designed to treat high-risk non-muscle-invasive bladder cancer (NMIBC) that does not respond to Bacillus Calmette-Guérin (BCG) therapy. It contains nadofaragene firadenovec, a non-replicating adenoviral vector that delivers the interferon alfa-2b gene directly to bladder cells. This process stimulates the local production of interferon alfa-2b, a protein with antitumor properties, enhancing the immune system's ability to target cancer cells.

The main types of indication for adstiladrin include high-risk non-muscle-invasive bladder cancer (NMIBC) and other bladder cancer variants. High-risk non-muscle-invasive bladder cancer (NMIBC) is a type of bladder cancer where the tumor is confined to the inner lining of the bladder and has a high potential for recurrence or progression. It is distributed through various channels, including hospitals and clinics, retail pharmacies, and specialty pharmacies, and is used by both adults and geriatrics.

Adstiladrin Market Segmentation

The adstiladrinmarket covered in this report is segmented –

1) By Indication: High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC), Other Bladder Cancer Variants

2) By Distribution Channel: Hospitals And Clinics, Retail And Specialty Pharmacies

3) By End User: Adult, Geriatric

Adstiladrin Market Size and growth rate 2025 to 2029: Graph

Adstiladrin Market Size 2025 And Growth Rate

The adstiladrin market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to increased approval for gene therapy products, rise in the number of patients diagnosed with urothelial carcinoma, increasing demand for immunotherapy, rise in the number of clinical trials, and increasing healthcare expenditures.

Adstiladrin Market Growth Forecast

The adstiladrin market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to increasing incidence of non-muscle-invasive bladder cancer, rising number of BCG-unresponsive cases, increasing investment in cancer research, rising global healthcare expenditure, and growing preference for gene therapy. Major trends in the forecast period include technological advancements, personalized medicine, adoption of biomarkers, artificial intelligence, and advances in liquid biopsy technology.

Book your 30 minutes free consultation with our research experts

Adstiladrin Market Driver: Rising Incidence Of Bladder Cancer Fuels Adstiladrin Market Growth

The rising incidence of bladder cancer is expected to drive the growth of the adstiladrin market going forward. Bladder cancer is a type of cancer that begins in the cells of the bladder, the hollow organ in the lower abdomen that stores urine. Bladder cancer is rising because of smoking, an aging population, environmental toxins, chronic bladder conditions, and better diagnostic methods. Adstiladrin is needed for bladder cancer treatment because it offers an effective option for high-risk non-muscle-invasive bladder cancer (NMIBC) patients unresponsive to BCG therapy, reducing the need for radical surgery. For instance, in January 2024, according to the American Cancer Society, a US-based nonprofit cancer advocacy organization, the number of urinary bladder cancer cases increased to 83,190 compared 82,290 in 2023, reflecting a growth of 1.09%. Therefore, the rising incidence of bladder cancer is driving the growth of the adstiladrin market.

Adstiladrin Market Driver: Rising Healthcare Expenditure Fueling Growth In The Adstiladrin Market

The rising healthcare expenditure is expected to propel the growth of the adstiladrin market going forward. Healthcare expenditure refers to the total amount of money spent by individuals, governments, and organizations on healthcare services, products, and infrastructure, including preventive, curative, rehabilitative, and palliative care. Healthcare expenditure is rising due to factors like aging populations, the prevalence of chronic diseases, advancements in medical technology, increased demand for healthcare services, and rising drug and treatment costs. Increased healthcare expenditure enables greater investment in advanced therapies like Adstiladrin, improving access to innovative treatments for high-risk bladder cancer patients. For instance, in May 2023, according to the Office for National Statistics, a UK-based government agency, the UK's healthcare expenditure reached approximately $348.0 billion (£283 billion) in 2022, marking a 0.7% increase in nominal terms compared to 2021. Non-government healthcare spending grew by 9.5% in nominal terms, or 3.9% in real terms, during the same period. Therefore, the rising healthcare expenditure is driving the adstiladrin market.

Global Adstiladrin Market Major Players

Major companies operating in the adstiladrin market include Ferring Pharmaceuticals Inc.

Global Adstiladrin Market Trend: Innovative Adenovirus Vector-Based Therapies Driving Advancements In The Adstiladrin Market

The key trend in the adstiladrin market is focusing on developing innovative products, such as adenovirus vector-based gene therapies, to improve treatment outcomes. Adenovirus vector-based gene therapy uses modified adenoviruses as delivery vehicles to transport therapeutic genes into target cells, enabling the treatment of genetic disorders or diseases. For instance, in December 2022, Ferring Pharmaceuticals, a Switzerland-based pharmaceutical company, received Food and Drug Administration (FDA) approval for Adstiladrin (nadofaragene firadenovec-vncg) for the treatment of adult patients with high-risk non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) that is not responsive to Bacillus Calmette-Guérin (BCG), either with or without papillary tumors. Adstiladrin is a unique intravesical therapy administered quarterly, designed to target the bladder wall cells and bolster the body's natural defenses against cancer. Its FDA approval stems from a successful Phase 3 clinical trial, where it achieved a complete response (CR) in 51% of patients with carcinoma in situ (CIS) with or without high-grade Ta or T1 disease within three months. Notably, 46% of these patients remained free from high-grade recurrence at 12 months, demonstrating its effectiveness in providing sustained cancer control.

Regional Outlook For The Global Adstiladrin Market

North America was the largest region in the adstiladrin market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the adstiladrin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the adstiladrin market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Adstiladrin Market?

The adstiladrin market consists of sales of gene therapy medications, adenoviral vectors, immune checkpoint inhibitors and recombinant proteins. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Adstiladrin Industry?

The adstiladrin market research report is one of a series of new reports from The Business Research Company that provides adstiladrin market statistics, including adstiladrin industry global market size, regional shares, competitors with a adstiladrin market share, detailed adstiladrin market segments, market trends and opportunities, and any further data you may need to thrive in the adstiladrin industry. This adstiladrin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Adstiladrin Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	CAGR of from 2025 to 2034
Revenue Forecast In 2034	2024
Growth Rate	2019-2024
Base Year For Estimation	2025 - 2029 - 2034
Actual Estimates/Historical Data	Revenue in USD Billion and CAGR from 2025 to 2034
Forecast Period	1) By Indication: High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC), Other Bladder Cancer Variants 2) By Distribution Channel: Hospitals And Clinics, Retail And Specialty Pharmacies 3) By End User: Adult, Geriatric
Market Representation	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Segments Covered	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Regional Scope	Ferring Pharmaceuticals Inc.
Country Scope	Request for Sample
Key Companies Profiled	Explore Purchase Options
Customization Scope
Pricing And Purchase Options

1. Executive Summary

2. Adstiladrin Market Characteristics

3. Adstiladrin Market Biologic Drug Characteristics

3.1. Molecule Type

3.2. Route Of Administration (ROA)

3.3. Mechanism Of Action (MOA)

3.4. Safety And Efficacy

4. Adstiladrin Market Trends And Strategies

5. Adstiladrin Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

6. Global Adstiladrin Growth Analysis And Strategic Analysis Framework

6.1. Global Adstiladrin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

6.2. Analysis Of End Use Industries

6.3. Global Adstiladrin Market Growth Rate Analysis

6.4. Global Adstiladrin Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

6.5. Global Adstiladrin Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

6.6. Global Adstiladrin Total Addressable Market (TAM)

7. Global Adstiladrin Market Pricing Analysis & Forecasts

8. Adstiladrin Market Segmentation

8.1. Global Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)

Other Bladder Cancer Variants

8.2. Global Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals And Clinics

Retail And Specialty Pharmacies

8.3. Global Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Adult

Geriatric

9. Global Adstiladrin Market Epidemiology Of Clinical Indications

9.1. Drug Side Effects

9.2. Incidence And Prevalence of Clinical Indications

10. Adstiladrin Market Regional And Country Analysis

10.1. Global Adstiladrin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. Global Adstiladrin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Asia-Pacific Adstiladrin Market

11.1. Asia-Pacific Adstiladrin Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Asia-Pacific Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Asia-Pacific Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. China Adstiladrin Market

12.1. China Adstiladrin Market Overview

12.2. China Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

12.3. China Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

12.4. China Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

13. India Adstiladrin Market

13.1. India Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. India Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. India Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. Japan Adstiladrin Market

14.1. Japan Adstiladrin Market Overview

14.2. Japan Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. Japan Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. Japan Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Australia Adstiladrin Market

15.1. Australia Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.2. Australia Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Australia Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. South Korea Adstiladrin Market

16.1. South Korea Adstiladrin Market Overview

16.2. South Korea Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. South Korea Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.4. South Korea Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Western Europe Adstiladrin Market

17.1. Western Europe Adstiladrin Market Overview

17.2. Western Europe Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Western Europe Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.4. Western Europe Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. UK Adstiladrin Market

18.1. UK Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. UK Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. UK Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Germany Adstiladrin Market

19.1. Germany Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Germany Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Germany Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. France Adstiladrin Market

20.1. France Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. France Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. France Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Adstiladrin Market

21.1. Eastern Europe Adstiladrin Market Overview

21.2. Eastern Europe Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. North America Adstiladrin Market

22.1. North America Adstiladrin Market Overview

22.2. North America Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. North America Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.4. North America Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. USA Adstiladrin Market

23.1. USA Adstiladrin Market Overview

23.2. USA Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. USA Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. USA Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. Canada Adstiladrin Market

24.1. Canada Adstiladrin Market Overview

24.2. Canada Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. Canada Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. Canada Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. South America Adstiladrin Market

25.1. South America Adstiladrin Market Overview

25.2. South America Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. South America Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. South America Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. Middle East Adstiladrin Market

26.1. Middle East Adstiladrin Market Overview

26.2. Middle East Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. Middle East Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. Middle East Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Africa Adstiladrin Market

27.1. Africa Adstiladrin Market Overview

27.2. Africa Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Africa Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.4. Africa Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Adstiladrin Market Competitive Landscape And Company Profiles

28.1. Adstiladrin Market Competitive Landscape

28.2. Adstiladrin Market Company Profiles

28.2.1. Ferring Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

29. Global Adstiladrin Market Pipeline Analysis

29.1. High Level Clinic Trail Information

30. Global Adstiladrin Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Adstiladrin Market

32. Recent Developments In The Adstiladrin Market

33. Adstiladrin Market High Potential Countries, Segments and Strategies

33.1 Adstiladrin Market In 2029 - Countries Offering Most New Opportunities

33.2 Adstiladrin Market In 2029 - Segments Offering Most New Opportunities

33.3 Adstiladrin Market In 2029 - Growth Strategies

33.3.1 Market Trend Based Strategies

33.3.2 Competitor Strategies

34. Appendix

34.1. Abbreviations

34.2. Currencies

34.3. Historic And Forecast Inflation Rates

34.4. Research Inquiries

34.5. The Business Research Company

34.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Adstiladrin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Adstiladrin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Asia-Pacific, Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Asia-Pacific, Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Asia-Pacific, Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: China, Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: China, Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: China, Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: India, Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: India, Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: India, Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: Japan, Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: Japan, Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: Japan, Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Australia, Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Australia, Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Australia, Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: South Korea, Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: South Korea, Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: South Korea, Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Western Europe, Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Western Europe, Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Western Europe, Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: UK, Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: UK, Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: UK, Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Germany, Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Germany, Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Germany, Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: France, Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: France, Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: France, Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Eastern Europe, Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Eastern Europe, Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Eastern Europe, Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: North America, Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: North America, Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: North America, Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: USA, Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: USA, Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: USA, Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Canada, Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Canada, Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Canada, Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: South America, Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: South America, Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: South America, Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Middle East, Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Middle East, Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Middle East, Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Africa, Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Africa, Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Africa, Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: Ferring Pharmaceuticals Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Adstiladrin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Adstiladrin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Asia-Pacific, Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Asia-Pacific, Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Asia-Pacific, Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: China, Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: China, Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: China, Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: India, Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: India, Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: India, Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: Japan, Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: Japan, Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: Japan, Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Australia, Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Australia, Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Australia, Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: South Korea, Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: South Korea, Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: South Korea, Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Western Europe, Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Western Europe, Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Western Europe, Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: UK, Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: UK, Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: UK, Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Germany, Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Germany, Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Germany, Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: France, Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: France, Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: France, Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Eastern Europe, Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Eastern Europe, Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Eastern Europe, Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: North America, Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: North America, Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: North America, Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: USA, Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: USA, Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: USA, Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Canada, Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Canada, Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Canada, Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: South America, Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: South America, Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: South America, Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Middle East, Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Middle East, Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Middle East, Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Africa, Adstiladrin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Africa, Adstiladrin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Africa, Adstiladrin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: Ferring Pharmaceuticals Inc. Financial Performance

Latest Gynecology Drugs Market Growth Study 2022-2026 By The Business Research Company

How Will The Nanomedicine Market Grow In 2022?

What Is The Naloxone Spray Market Overview In 2022?

Global Multivitamin Capsules And Tablets Market 2022 – Market Opportunities And Strategies

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the oral biologics and biosimilars market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the insulin drugs market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the hiv drugs market research report 2022 with industry size, share, segments and market growth

Darbepoetin Alfa (Aranesp) Global Market Report 2025 – By Type (Epogen, Procrit, Aranesp, Other Types), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Application (Patients with Chronic Kidney Disease, Patients with Cancer, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Hepatitis B Virus (HBV) Global Market Report 2025 – By Type (Acute, Chronic), By Treatment (Immune Modulator Drugs, Antiviral Drugs, Vaccine, Surgery), By Age Group (Pediatrics, Adults, Seniors), By End User (Medical Providers, Patients, Healthcare Payers) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Rotavirus Prophylaxis Global Market Report 2025 – By Treatment (Rotarix, Rotavac, Rotavin-M1, Oral Rehydration Fluid, Other Treatments), By Route of Administration (Oral, Parenteral, Other Route of Administrations), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels), By End-Users (Hospitals, Specialty Clinics, Homecare, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Herpes Simplex Virus Treatment Global Market Report 2025 – By Type (Herpes Simplex Virus-1 Infection, Herpes Simplex Virus-2 Infection), By Drug Type (Acyclovir, Valacyclovir, Famciclovir, Other Drugs), By Route Of Administration (Oral, Injection, Topical), By Vaccine (Simplirix, Other Vaccines), By Distribution Channel (Hospital Pharmacies, Drug store, Retail Pharmacies, Online Providers) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Human Papillomavirus (HPV) Vaccine Global Market Report 2025 – By Type (Tetravalent, Nonavalent, Bivalent), By Disease Indication (Cervical Cancer, Anal Cancer, Vulvar And Vaginal Cancer, Penile Cancer, Oropharyngeal Cancer, Other Indications), By Distribution Channel (Hospital And Retail Pharmacies, Government Suppliers, Other Channels), By Industry Vertical (Public And Private Alliance, Government Entities, Physicians, Other Industries) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Oncolytic Virus Therapy Global Market Report 2025 – By Therapy Type (HSV-Based Oncolytic Virus Therapy, Adenovirus-Based Oncolytic Virus Therapy, Reovirus, Poxviruses, NDV (Newcastle Disease Virus), Other Therapy Types), By Virus Type (Genetically Engineered Oncolytic Viruses, Oncolytic Wild-Type Viruses), By Application (Breast Cancer, Lung Cancer, Prostate Cancer, Melanoma, Brain Tumor, Blood Cancer), By End-User (Hospitals, Specialty Clinics, Cancer Research Institutes) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Respiratory Syncytial Virus (RSV) Therapeutics Global Market Report 2025 – By Drug (Palivizumab, Ribavirin, Other Drugs), By Treatment (Immune Prophylaxis, Supportive Care, Antiviral Medications), By Dosage Form (Oral, Injectable, Other Dosage Forms), By Patient Type (Pediatrics, Adults), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Human Immunodeficiency Virus (HIV) Diagnosis Global Market Report 2025 – By Product (Consumables, Instruments, Software And Services), By Mode (Self-Test, Lab-Based), By End User (Diagnostic Laboratories, Hospitals, Research Institutions) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Adstiladrin market?

How will the Adstiladrin market drivers and restraints affect the market dynamics? What forces will shape the Adstiladrin industry going forward?

The Adstiladrin market major growth driver - Rising Incidence Of Bladder Cancer Fuels Adstiladrin Market Growth. For further insights on the Adstiladrin market, request a sample here

What is the forecast market size or the forecast market value of the Adstiladrin market?

The Adstiladrin market size has grown strongly in recent years. The adstiladrin market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to increased approval for gene therapy products, rise in the number of patients diagnosed with urothelial carcinoma, increasing demand for immunotherapy, rise in the number of clinical trials, and increasing healthcare expenditures. The adstiladrin market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to increasing incidence of non-muscle-invasive bladder cancer, rising number of BCG-unresponsive cases, increasing investment in cancer research, rising global healthcare expenditure, and growing preference for gene therapy. Major trends in the forecast period include technological advancements, personalized medicine, adoption of biomarkers, artificial intelligence, and advances in liquid biopsy technology. For further insights on the Adstiladrin market, request a sample here

How is the Adstiladrin market segmented?

The adstiladrinmarket covered in this report is segmented –
1) By Indication: High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC); Other Bladder Cancer Variants
2) By Distribution Channel: Hospitals And Clinics; Retail And Specialty Pharmacies
3) By End User: Adult; Geriatric For further insights on the Adstiladrin market, request a sample here

Which region has the largest share of the Adstiladrin market? What are the other regions covered in the report?

Who are the major players in the Adstiladrin market?

Major companies operating in the adstiladrin market include Ferring Pharmaceuticals Inc. . For further insights on the Adstiladrin market, request a sample here.

What are the key trends in the Adstiladrin market?

Major trends in the Adstiladrin market include Innovative Adenovirus Vector-Based Therapies Driving Advancements In The Adstiladrin Market. For further insights on the Adstiladrin market, request a sample here.

What are the major opportunities in the Adstiladrin market? What are the strategies for the Adstiladrin market?

For detailed insights on the major opportunities and strategies in the Adstiladrin market, request a sample here.

How does the Adstiladrin market relate to the overall economy and other similar markets?

For detailed insights on Adstiladrin's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Adstiladrin industry?

For detailed insights on the mergers and acquisitions in the Adstiladrin industry, request a sample here.

What are the key dynamics influencing the Adstiladrin market growth? SWOT analysis of the Adstiladrin market.

For detailed insights on the key dynamics influencing the Adstiladrin market growth and SWOT analysis of the Adstiladrin industry, request a sample here.